OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis.
OT-82 是一种新型抗癌候选药物，它针对血液恶性肿瘤对 NAD 生物合成的强烈依赖性
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-019-0692-5
Korotchkina Lioubov, Kazyulkin Denis, Komarov Pavel G, Polinsky Alex, Andrianova Ekaterina L, Joshi Sangeeta, Gupta Mahima, Vujcic Slavoljub, Kononov Eugene, Toshkov Ilia, Tian Yuan, Krasnov Peter, Chernov Mikhail V, Veith Jean, Antoch Marina P, Middlemiss Shiloh, Somers Klaartje, Lock Richard B, Norris Murray D, Henderson Michelle J, Haber Michelle, Chernova Olga B, Gudkov Andrei V
